Immunotation of Rv2753c (dihydrodipicolinate synthase)
From DrugPedia: A Wikipedia for Drug discovery
(Difference between revisions)
| Line 47: | Line 47: | ||
[[Category:Hormones]] | [[Category:Hormones]] | ||
| + | [[Category:Eli Lilly and Company]] | ||
| + | [[Category:Recombinant proteins]] | ||
| + | [[Category:Peptide hormones]] | ||
| + | [[Category:Pancreatic hormones]] | ||
| + | [[Category:Insulin therapies]] | ||
| + | [[Category:Anti-diabetic drugs]] | ||
Revision as of 09:15, 9 December 2009
| |
| |
| Immunotation of Rv2753c (dihydrodipicolinate synthase)
| |
| Systematic (IUPAC) name | |
| (8R,9S,10R,13S,14S,17S)- 17-hydroxy-10,13-dimethyl- 1,2,6,7,8,9,11,12,14,15,16,17- dodecahydrocyclopenta[a] phenanthren-3-one | |
| Identifiers | |
| CAS number | 57-85-2 (propionate ester) |
| ATC code | ? |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| Chemical data | |
| Formula | C19H28O2 |
| Mol. mass | 288.42 |
| SMILES | & |
| Physical data | |
| Melt. point | 1550deg C EXP °C |
| Solubility in water | 23.4 mg/L at 250C EXP mg/mL |
| Spec. rot | +110,2° |
| SEC Combust | −11080 kJ/mol |
| Pharmacokinetic data | |
| Bioavailability | low (due to extensive first pass metabolism) |
| Metabolism | Liver, Testis and Prostate |
| Half life | 2-4 hours |
| Excretion | Urine (90%), feces (6%) |
| Therapeutic considerations | |
| Pregnancy cat. |
X (USA), Teratogenic effects |
| Legal status | |
| Routes | Intramuscular injection, transdermal (cream, gel, or patch), sub-'Q' pellet |
Contents |
